Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Genotype-phenotype correlations in pheochromocytoma and paraganglioma.

Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K.

Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0024.R2. doi: 10.1530/ERC-19-0024. [Epub ahead of print]

PMID:
30893643
2.

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective.

Crona J, Backman S, Welin S, Taïeb D, Hellman P, Stålberg P, Skogseid B, Pacak K.

Cancers (Basel). 2018 Dec 15;10(12). pii: E518. doi: 10.3390/cancers10120518.

3.

Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.

Razmara M, Monazzam A, Skogseid B.

Cell Commun Signal. 2018 Oct 1;16(1):64. doi: 10.1186/s12964-018-0278-2.

4.

Advances in adrenal tumors 2018.

Crona J, Beuschlein F, Pacak K, Skogseid B.

Endocr Relat Cancer. 2018 Jul;25(7):R405-R420. doi: 10.1530/ERC-18-0138. Review.

5.

Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 /PET.

Monazzam A, Lau J, Velikyan I, Li SC, Razmara M, Rosenström U, Eriksson O, Skogseid B.

Sci Rep. 2018 Jan 15;8(1):748. doi: 10.1038/s41598-017-18855-0.

6.

Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.

Backman S, Norlén O, Eriksson B, Skogseid B, Stålberg P, Crona J.

Anticancer Res. 2017 Feb;37(2):705-712.

PMID:
28179320
7.

An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors.

Stålberg K, Crona J, Razmara M, Taslica D, Skogseid B, Stålberg P.

Int J Gynecol Cancer. 2016 Jul;26(6):1027-32. doi: 10.1097/IGC.0000000000000721.

PMID:
27177282
8.

GEP- NETS UPDATE: Genetics of neuroendocrine tumors.

Crona J, Skogseid B.

Eur J Endocrinol. 2016 Jun;174(6):R275-90. doi: 10.1530/EJE-15-0972. Review.

PMID:
27165966
9.

Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model.

Barbu A, Lejonklou MH, Skogseid B.

Pancreas. 2016 Apr;45(4):533-40. doi: 10.1097/MPA.0000000000000509.

PMID:
26495792
10.

Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity.

Clewemar Antonodimitrakis P, Sundin A, Wassberg C, Granberg D, Skogseid B, Eriksson B.

Neuroendocrinology. 2016;103(3-4):345-53. doi: 10.1159/000439086. Epub 2015 Aug 7.

PMID:
26279284
11.

Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma.

Kerkhofs TM, Baudin E, Terzolo M, Allolio B, Chadarevian R, Mueller HH, Skogseid B, Leboulleux S, Mantero F, Haak HR, Fassnacht M.

J Clin Endocrinol Metab. 2013 Dec;98(12):4759-67. doi: 10.1210/jc.2013-2281. Epub 2013 Sep 20.

12.

Multiple microvascular alterations in pancreatic islets and neuroendocrine tumors of a Men1 mouse model.

Chu X, Gao X, Jansson L, Quach M, Skogseid B, Barbu A.

Am J Pathol. 2013 Jun;182(6):2355-67. doi: 10.1016/j.ajpath.2013.02.023. Epub 2013 Apr 12.

PMID:
23583653
13.

[Early bridge between preclinical and clinical research].

Staaf J, Akerström T, Ljungström V, Larsson S, Karlsson T, Skogseid B, Bergsten P.

Lakartidningen. 2012 Apr 25-May 8;109(17-18):898. Swedish. No abstract available.

PMID:
22642061
14.

Combination chemotherapy in advanced adrenocortical carcinoma.

Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group.

N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2.

15.

Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.

Lejonklou MH, Barbu A, Stålberg P, Skogseid B.

Endocrinology. 2012 Jun;153(6):2588-98. doi: 10.1210/en.2011-1924. Epub 2012 Apr 4.

PMID:
22492302
16.

PET-Guided Surgery - High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine Tumours.

Orlefors H, Sundin A, Eriksson B, Skogseid B, Oberg K, Akerström G, Hellman P.

Cancers (Basel). 2012 Feb 8;4(1):100-12. doi: 10.3390/cancers4010100.

17.

Prognostic relevance of survivin in pancreatic endocrine tumors.

Ekeblad S, Lejonklou MH, Stålberg P, Skogseid B.

World J Surg. 2012 Jun;36(6):1411-8. doi: 10.1007/s00268-011-1345-7.

18.

Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer.

Lindhe O, Skogseid B.

Horm Metab Res. 2010 Sep;42(10):725-30. doi: 10.1055/s-0030-1261923. Epub 2010 Jul 27.

PMID:
20665429
19.

Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.

Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, Skogseid B, Allolio B, Terzolo M.

J Clin Oncol. 2010 Aug 10;28(23):e401-2; author reply e403. doi: 10.1200/JCO.2009.27.5958. Epub 2010 Jun 21. No abstract available.

PMID:
20567001
20.

Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec).

Kindmark H, Janson ET, Gustavsson B, Eriksson C, Larsson G, Granberg D, Kozlowacki G, Skogseid B, Welin S, Oberg K, Eriksson B.

Acta Oncol. 2010;49(1):100-1. doi: 10.3109/02841860902897707. No abstract available.

PMID:
20100145
21.

Spectral karyotypic and comparative genomic analysis of the endocrine pancreatic tumor cell line BON-1.

Lopez JR, Claessen SM, Macville MV, Albrechts JC, Skogseid B, Speel EJ.

Neuroendocrinology. 2010;91(2):131-41. doi: 10.1159/000254483. Epub 2009 Oct 29.

PMID:
19887762
22.

The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors.

Tacon LJ, Soon PS, Gill AJ, Chou AS, Clarkson A, Botling J, Stalberg PL, Skogseid BM, Robinson BG, Sidhu SB, Clifton-Bligh RJ.

J Clin Endocrinol Metab. 2009 Nov;94(11):4591-9. doi: 10.1210/jc.2009-0546. Epub 2009 Oct 9.

PMID:
19820023
23.
24.

Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays.

Lopez-Egido JR, Wang Y, Grönberg M, Grimfjärd P, Wang S, Stålberg P, Skogseid B.

Anticancer Res. 2009 Jun;29(6):1859-66.

25.

Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells.

Lejonklou MH, Edfeldt K, Johansson TA, Stålberg P, Skogseid B.

Pancreas. 2009 Apr;38(3):259-66. doi: 10.1097/MPA.0b013e3181930818.

PMID:
19307926
26.

Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.

Welin S, Stridsberg M, Cunningham J, Granberg D, Skogseid B, Oberg K, Eriksson B, Janson ET.

Neuroendocrinology. 2009;89(3):302-7. doi: 10.1159/000179900. Epub 2009 Jan 29.

PMID:
19176944
27.

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.

Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B.

Clin Cancer Res. 2008 Dec 1;14(23):7798-803. doi: 10.1158/1078-0432.CCR-08-0734.

28.

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.

Lim E, Goldstraw P, Nicholson AG, Travis WD, Jett JR, Ferolla P, Bomanji J, Rusch VW, Asamura H, Skogseid B, Baudin E, Caplin M, Kwekkeboom D, Brambilla E, Crowley J.

J Thorac Oncol. 2008 Oct;3(10):1194-201. doi: 10.1097/JTO.0b013e3181861d7b.

29.

Lack of nuclear expression of hairy and enhancer of split-1 (HES1) in pancreatic endocrine tumors.

Johansson T, Lejonklou MH, Ekeblad S, Stålberg P, Skogseid B.

Horm Metab Res. 2008 May;40(5):354-9. doi: 10.1055/s-2008-1076695.

PMID:
18491256
30.

Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.

Eriksson J, Stålberg P, Nilsson A, Krause J, Lundberg C, Skogseid B, Granberg D, Eriksson B, Akerström G, Hellman P.

World J Surg. 2008 May;32(5):930-8. doi: 10.1007/s00268-008-9510-3.

PMID:
18324347
31.

DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.

Jonkers YM, Claessen SM, Perren A, Schmitt AM, Hofland LJ, de Herder W, de Krijger RR, Verhofstad AA, Hermus AR, Kummer JA, Skogseid B, Volante M, Voogd AC, Ramaekers FC, Speel EJ.

Endocr Relat Cancer. 2007 Sep;14(3):769-79.

PMID:
17914106
32.

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.

Kindmark H, Sundin A, Granberg D, Dunder K, Skogseid B, Janson ET, Welin S, Oberg K, Eriksson B.

Med Oncol. 2007;24(3):330-7.

PMID:
17873310
33.

Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.

Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskjöld M.

J Clin Endocrinol Metab. 2007 Sep;92(9):3389-95. Epub 2007 Jul 10.

PMID:
17623761
34.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Ekeblad S, Sundin A, Janson ET, Welin S, Granberg D, Kindmark H, Dunder K, Kozlovacki G, Orlefors H, Sigurd M, Oberg K, Eriksson B, Skogseid B.

Clin Cancer Res. 2007 May 15;13(10):2986-91.

35.

Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors.

Granberg D, Eriksson LG, Welin S, Kindmark H, Janson ET, Skogseid B, Oberg K, Eriksson B, Nyman R.

Acta Radiol. 2007 Mar;48(2):180-5.

PMID:
17354139
36.

Co-expression of ghrelin and its receptor in pancreatic endocrine tumours.

Ekeblad S, Lejonklou MH, Grimfjärd P, Johansson T, Eriksson B, Grimelius L, Stridsberg M, Stålberg P, Skogseid B.

Clin Endocrinol (Oxf). 2007 Jan;66(1):115-22.

PMID:
17201810
37.

Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.

Stålberg P, Santesson M, Ekeblad S, Lejonklou MH, Skogseid B.

Surgery. 2006 Dec;140(6):921-9; discussion 929-31. Epub 2006 Nov 1.

PMID:
17188139
38.

Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.

Jonkers YM, Claessen SM, Veltman JA, Geurts van Kessel A, Dinjens WN, Skogseid B, Ramaekers FC, Speel EJ.

Cytogenet Genome Res. 2006;115(3-4):289-97.

PMID:
17124412
39.

[Lung carcinoids--not so benign as earlier believed].

Granberg D, Eriksson B, Janson ET, Oberg K, Skogseid B.

Lakartidningen. 2006 Aug 23-29;103(34):2382-4. Review. Swedish. No abstract available.

PMID:
16972494
40.

Gastrointestinal stromal tumors express the orexigen ghrelin.

Ekeblad S, Nilsson B, Lejonklou MH, Johansson T, Stålberg P, Nilsson O, Ahlman H, Skogseid B.

Endocr Relat Cancer. 2006 Sep;13(3):963-70.

PMID:
16954444
41.

Gastrin-releasing-peptide in neuroendorine tumours.

Granberg D, Skogseid B, Welin S, Orlefors H, Oberg K, Wilander E.

Acta Oncol. 2006;45(1):23-7.

PMID:
16464792
42.

Pancreatic tumours as part of the MEN-1 syndrome.

Akerström G, Hessman O, Hellman P, Skogseid B.

Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):819-30. Review.

PMID:
16253903
43.

Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.

Hellman P, Hennings J, Akerström G, Skogseid B.

Br J Surg. 2005 Dec;92(12):1508-12.

PMID:
16231278
44.

Radiofrequency ablation of neuroendocrine liver metastases.

Elvin A, Skogseid B, Hellman P.

Abdom Imaging. 2005 Jul-Aug;30(4):427-34. No abstract available.

PMID:
15791486
45.

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.

Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, Langstrom B, Bergstrom M, Eriksson B.

J Clin Endocrinol Metab. 2005 Jun;90(6):3392-400. Epub 2005 Mar 8.

PMID:
15755858
46.

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.

Welin SV, Janson ET, Sundin A, Stridsberg M, Lavenius E, Granberg D, Skogseid B, Oberg KE, Eriksson BK.

Eur J Endocrinol. 2004 Jul;151(1):107-12.

PMID:
15248829
47.
48.

Octreoscan in patients with bronchial carcinoid tumours.

Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE.

Clin Endocrinol (Oxf). 2003 Dec;59(6):793-9.

PMID:
14974924
49.

In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours.

Stålberg P, Granberg D, Carling T, Wilander E, Eriksson B, Gobl A, Akerström G, Rastad J, Modlin IM, Oberg K, Skogseid B.

Anticancer Res. 2003 May-Jun;23(3B):2227-32.

PMID:
12894496
50.

Multiple endocrine neoplasia type 1.

Skogseid B.

Br J Surg. 2003 Apr;90(4):383-5. No abstract available.

PMID:
12673737

Supplemental Content

Loading ...
Support Center